CNRL in silico exercise to determine the capabilities of network laboratories to detect triple reassortant swine origin influenza A(H3N2) viruses
Following the emergence of swine influenza A(H3N2) variant (v) viruses with sporadic human infections in North America, the Community Network of Reference Laboratories (CNRL) and the Animal Health and Veterinary Laboratories Agency completed an exercise to assess the CNRL’s capability to detect novel reassortant and circulating triple reassortant swine viruses (TRA) in humans.
Influenza A(H3N2)v laboratory detection questionnaire results
Following the emergence of swine influenza A(H3N2) variant (v) viruses with sporadic human infections in North America, ECDC and the Community Network of Reference Laboratories (CNRL) disseminated a questionnaire to explore the RT-PCR capability of influenza reference laboratories in EU/EEA countries to detect A(H3N2)v viruses in their day-to-day diagnostics and to subtype them as swine-origin variant viruses.
Risk assessment: Avian Influenza A/H5N1 in Bathing and Potable (Drinking) Water and Risks to Human Health
Avian influenza A/H5N1: Collected risk assessments, technical guidance to public health authorities and advice to the general public
The document determines the risk to human health in Europe from highly pathogenic avian influenza viruses in birds and animals and identifies areas requiring additional scientific and public health work both as single pieces of work and for risk monitoring by ECDC and its partners.
Oseltamivir Prophylaxis Following Suspected Exposure of Humans to Highly Pathogenic Avian Influenza
Oseltamivir Prophylaxis Following Suspected Exposure of Humans to Highly Pathogenic Avian Influenza (HPAI) with Particular Reference to HPAI type A/H5N1.